Health & Science

Psychedelic Legislative Trends in 2024: A Detailed Overview

Jun 20 • 6 min read

The first half of 2024 has been captivating for several reasons. Oregon’s regulated access program has been operational for eighteen months, serving thousands with psilocybin services. Meanwhile, Colorado is navigating the complexities of decriminalizing multiple sacred plants and establishing a rulemaking process. Across the country, states are learning from past policy efforts—both successful and not—implementing…

Psychedelic Retreats Market Set to Cross $1 Trillion By 2027

Jun 14 • 6 min read

The market for psychedelic retreats is on a remarkable trajectory, with projections indicating it will surpass the $1 trillion mark by 2027. This anticipated milestone reflects the rapid expansion and increasing acceptance of psychedelic therapy as an effective treatment for various mental health conditions. The combination of scientific research, regulatory advancements, and shifting societal attitudes…

UC Berkeley’s Groundbreaking Study Exploring Psilocybin’s Effects on Perception

Jun 14 • 6 min read

The UC Berkeley Center for the Science of Psychedelics has embarked on an unprecedented study to explore why psilocybin, a psychoactive compound found in certain mushrooms, alters visual perception in humans. This investigation represents the university’s first human trials involving a Schedule I substance, classified by the federal government as having no accepted medical use….

Lykos Therapeutics Addresses Concerns Over MDMA Treatment for PTSD

Jun 14 • 5 min read

A week after an FDA committee voted against recommending midomafetamine (MDMA) treatment for post-traumatic stress disorder (PTSD), Lykos Therapeutics is working to clarify the situation and address concerns that have emerged in the broader conversation. This effort comes in the wake of significant public discourse surrounding the potential benefits and risks associated with the psychoactive…

Effective Psychedelic Treatment for Long-COVID Symptoms: A Case Study

Jun 7 • 4 min read

Long-COVID, also known as post-acute sequelae of SARS-CoV-2 infection, encompasses a range of symptoms that persist even after an individual has seemingly recovered from COVID-19. These symptoms can include cognitive impairment, fatigue, depression, anxiety, headaches, and joint pain. Currently, effective treatments for long-COVID are limited. However, a recent case study has highlighted the potential of…

Pages: 1234567891011121314